Diagnomed Clinical Research Sp. z.o.o.

Katowice 40-594

0 studies enrolling now · 2 studies all time

What they study most

Central Neuropathic Pain, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive

Studies at this site

• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed